The Effect of Early Screening and Intervention for Gestational Diabetes Mellitus on Pregnancy Outcomes
NCT03523143 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 967
Last updated 2024-10-18
Summary
Context: Women with gestational diabetes have excessive fetus growth weeks earlier than the screening period recommended currently, suggesting that earlier screening and intervention may improve pregnancy outcomes and the health of the offspring.
Objective: To determine if early screening and intervention could alter pregnancy outcomes, the incidence of maternal diabetes after delivery, and growth and development of the offspring, compared to the standard group.
Design, Setting, Participants: We will conduct a multi-center open-label randomized controlled trial in 2068 pregnant women, who deliver a singleton and who have not been diagnosed with overt diabetes mellitus at National Taiwan University Hospital (NTUH) and NTUH Hsinchu Branch from 2018 to 2020.
Interventions: Gestational diabetes mellitus (GDM) is diagnosed by a 75g 2-hour OGTT at 18-20 weeks of GA for the early-screening group and at 24-28 weeks for the standard-screening group. The diagnostic cutoffs are according to the IADPSG criteria. GDM is diagnosed if one of the plasma glucose levels at fasting, 1-hour, and 2-hour during OGTT is above 92 mg/dL, 180 mg/dL, or 153 mg/dL respectively. Subjects who are diagnosed with GDM receive lifestyle intervention and self-monitoring of blood glucose. Pharmacological therapies are given when the target of glycemic control is not achieved within 4-6 weeks.
Main Outcome Measure: The primary outcome is a composite measure of pregnancy outcomes, including primary CS, birth weight \>90th percentile, neonatal hypoglycemia, cord serum C-peptide \>90th percentile, pregnancy-induced hypertension, preeclampsia, and birth trauma. The primary outcome is measured within the entire period of perinatal and neonatal intensive-care units (NICU) stay for infants and the entire period of gestation for pregnant women after randomization.
Conclusion: This study will test our hypothesis that early screening and intervention of GDM improves pregnancy outcomes as compared to standard practice.
Conditions
- Pregnancy Complications
- Gestational Diabetes Mellitus in Pregnancy
Interventions
- OTHER
-
early screening and intervention
The early screening group will be screened by a 75g 2-hour oral glucose tolerance test (OGTT) at 18-20 weeks of gestational age (GA). Gestational diabetes mellitus (GDM) is diagnosed according to the IADPSG criteria. Subjects diagnosed with GDM will receive nutrition counseling, and lifestyle intervention. Pharmacologic therapies exclusively with human insulin or insulin analogues will be given when the target of glycemic control is not achieved within 4 weeks. The process of screening and intervention in the early screening group is all the same with that in the standard screening group. The only difference between two groups is the time of screening and intervention (18-20 weeks vs. 24-28 weeks of GA).
- OTHER
-
standard screening and intervention
The standard screening group will be screened by a 75g 2-hour oral glucose tolerance test (OGTT) at 24-28 weeks of gestational age (GA). Gestational diabetes mellitus (GDM) is diagnosed according to the International Association of Diabetes and Pregnancy Study Group (IADPSG) criteria, ie. if one of the plasma glucose levels at fasting, 1-hour, and 2-hour during OGTT is above 92 mg/dL, 180 mg/dL, and 153 mg/dL, respectively. Subjects diagnosed with GDM will receive nutrition counseling, and lifestyle intervention. Pharmacologic therapies exclusively with human insulin or insulin analogues will be given when the target of glycemic control is not achieved within 4 weeks.
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Hung-Yuan Li, Ph.D. · National Taiwan University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-06-11
- Primary Completion
- 2021-12-13
- Completion
- 2022-01-26
Countries
- Taiwan
Study Locations
More Related Trials
-
The Early Diagnosis of Gestational Diabetes Mellitus Study
NCT02740283 ·Status: UNKNOWN ·Phase: NA
-
Early Screen and Treatment for Gestational Diabetes
NCT02377531 ·Status: UNKNOWN ·Phase: NA
-
Early Detection of Gestational Diabetes Mellitus in Pregnancy
NCT05388643 ·Status: RECRUITING ·Phase: NA
-
Early Screening of Gestational Diabetes Mellitus and Prospective Cohort Study of Postpartum Follow-up
NCT03825926 ·Status: RECRUITING
-
Universal Hemoglobin A1c Versus Risk-based Screening for Early Gestational Diabetes Mellitus (EARLY GDM): A Randomized Controlled Trial
NCT06190405 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Continuous Glucose Monitoring for Screening for Diabetes in Pregnancy
NCT05430204 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Screening Strategies for Gestational Diabetes (GDM2)
NCT02309138 ·Status: COMPLETED ·Phase: NA
-
Gestational Diabetes Mellitus (GDM) in Pregnant Women
NCT05265741 ·Status: UNKNOWN
-
Diagnostic Analysis of Oral Glucose Tolerance Test in Early Pregnancy for Gestational Diabetes Mellitus
NCT05487352 ·Status: UNKNOWN
-
Oral Glucose Tolerance Testing After Gestational Diabetes
NCT02082301 ·Status: COMPLETED
-
Influence of Chrono-nutrition Factors and Temporal Dietary Patterns on Glycemic Parameters During Pregnancy.
NCT06215352 ·Status: RECRUITING
-
Early Versus Late Monitoring Among Pregnant Women With a History of Gestational Diabetes
NCT06545227 ·Status: RECRUITING
-
Randomizing Two Gestational Diabetes Screening Methods in a Diverse HMO
NCT02266758 ·Status: UNKNOWN ·Phase: NA
-
Risk Factors and Diagnostic Performance of Predictors as a Screening Technique for Gestational Diabetes Mellitus
NCT06109597 ·Status: COMPLETED
-
The Effect of E-Health Management on Gestational Diabetes Control
NCT03726983 ·Status: COMPLETED ·Phase: NA
-
The Effect of Early Nutrition Intervention on the Incidence of High-risk Patients With Gestational Diabetes
NCT03550976 ·Status: UNKNOWN ·Phase: NA
-
Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus
NCT04857073 ·Status: COMPLETED ·Phase: NA
-
Screening For First Trimester's Hyperglycemia in High and Low Risk Pregnancy
NCT06064552 ·Status: UNKNOWN
-
Stratification of Risk of Diabetes in Early Pregnancy
NCT03005600 ·Status: UNKNOWN
-
Studying Phenotypes of Gestational Diabetes Mellitus in an Asian Pregnant Cohort
NCT06542718 ·Status: RECRUITING
-
Gestational Diabetes Diagnostic Methods
NCT01540396 ·Status: COMPLETED ·Phase: NA
-
Early Intervention for Gestational Diabetes
NCT01171456 ·Status: WITHDRAWN ·Phase: NA
-
Pregnancy Outcomes and Medical Costs According to Gestational Diabetes Mellitus Diagnostic Criteria
NCT03421262 ·Status: UNKNOWN ·Phase: NA
-
Fasting Versus Fed: Effect of Oral Intake Prior to the Glucose Tolerance Test in Pregnancy
NCT04547023 ·Status: COMPLETED ·Phase: NA
-
An RCT to Evaluate Incidence, Cost and Clinical Outcomes Using 75 vs 100g. Screening Methods for Gestational Diabetes
NCT00295659 ·Status: COMPLETED